A new drug reduces risk of psychosis relapse in patients with dementia
Read now →Pimavanserin has not received approval from the FDA, but study results are encouraging
Soren Emerson
Neuroscience
Vanderbilt University
Soren Emerson is a an entering first year PhD student in the Vanderbilt University neuroscience program. He previously attended, and graduated from, Davidson College with a B.S. in neuroscience. He conducted three years of independent research at Davidson College under the mentorship of Dr. Mark Smith, a behavioral pharmacologist, and Dr. Rachid El Bejjani, a C. elegans neurobiologist. His research modeled the genetic and molecular mechanism of cocaine in C. elegans and the results of the project yielded a first author publication. At Vanderbilt, Soren plans to continue his research career in neuropharmacology.
Psilocybin reduced depression symptoms as much as a leading antidepressant
Read now →New research compared the "magic mushrooms" component to Lexapro
.jpeg?auto=compress%2Cformat&crop=faces&fit=crop&fm=jpg&h=800&q=70&w=1200)
Tapering off opioids is treacherous for mental health
Read now →A large-scale study shows how the opioid epidemic has created downstream negative health outcomes
New machine learning approach can identify your circadian rhythm from a blood sample
Read now →Doctors do not currently monitor a person's circadian rhythms because there is not an efficient way to measure them
Drinking way, way too much coffee might shrink your brain
Read now →Up to five cups of coffee per day seems to be fine. Six or more? Your brain is going to feel it
What nematodes laying eggs tells us about how cocaine affects the brain
Read now →New research uncovers a link between cocaine and acetylcholine that could eventually lead to new treatments for addiction
Drug overdose deaths in the US jumped nearly 30 percent in 2020
Read now →The story behind these numbers is complex, but opioids have played a major role
Modified tree resins prevent zebrafish from having seizures
Read now →Could these resins also be used to treat epilepsy in humans?
Laughing gas could be the next tool against treatment-resistant depression
Read now →A small clinical trial shows promise for people who don't find relief from antidepressants
Could blockchain technology protect patients from counterfeit medication?
Read now →Not so fast. We should be wary of trying to science our way out of large-scale health issues
2 peer comments
New drug addresses long overlooked "negative" symptoms of schizophrenia
Read now →A data-driven search found a compound that shows promising results in early trials
3 peer comments
We must reckon with our ableism if we want healthcare to work for people
Read now →People who had COVID-19 may need long-term care — the US healthcare system isn't ready
6 peer comments
5a48.jpg?auto=compress%2Cformat&crop=faces&fit=crop&fm=jpg&h=360&q=70&w=540)
The lab-leak hypothesis for COVID-19 is becoming a conspiracy theory
Read now →To explain where SARS-CoV-2 came from, look at processes with scientific explanations and precedents
5 peer comments